Episode Details

Back to Episodes
Vaccines and increasing infections

Vaccines and increasing infections

Published 1 week ago
Description
To message Danie, https://www.tiktok.com/@danielshep60?lang=en Pick and mix, mix and match https://www.washingtonpost.com/nation/2021/10/21/covid-delta-variant-live-updates/ Moderna and Johnson & Johnson can now have boosters Rochelle Walensky Choose any of the three boosters now authorized, regardless of original shot The evidence shows that all three COVID-19 vaccines authorized in the United States are safe, as demonstrated by the over 400 million vaccine doses already given And, they are all highly effective in reducing the risk of severe disease, hospitalization, and death, even in the midst of the widely circulating delta variant FDA, did not recommend any particular combination of vaccines and boosters to switch or to stick CDC, still working it out Advisory panel member Pablo J. Sanchez, pediatrician, Ohio State I agree that those who received a [Johnson & Johnson] vaccine should receive a second dose, I would prefer that those individuals get an mRNA vaccine FDA has authorized A third shot of Moderna or Pfizer-BioNTech anyone 65 and older any adults at high risk of severe, underlying conditions, job exposure, institutional settings At least six months since their second dose Johnson & Johnson recipients Anyone 18 and older At least two months since getting the shot In the fully vaccinated 105 million people, Pfizer series 70 million people, Moderna series 15 million people, Johnson & Johnson single shot More than 11 million people boosted so far UK https://covid.joinzoe.com/data#levels-over-time https://coronavirus.data.gov.uk CMOs slides https://www.gov.uk/government/publications/slides-to-accompany-coronavirus-press-conference-20-october-2021 Sajid Javid, cases could rise to 100,000 per day this winter Sage October report https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1027514/S1381_SAGE_96_minutes.pdf Risk posed by further viral evolution, that becomes dominant globally is a very real possibility Therefore need for: Capacity to monitor for variants Conduct predictive vaccinology Winter and into 2022 Hospital admissions above the level seen in January 2021 are increasingly unlikely https://coronavirus.data.gov.uk/details/healthcare Uncertainties, behaviour change and waning immunity Co-circulation and co-infection of SARS-CoV-2 with Respiratory Syncytial Virus (RSV) and influenza Symptoms of any respiratory infection, stay at home Russia Deaths, + 1,000 per day https://www.bbc.co.uk/news/world-europe-58998366 Vologda, Hospital Number One 26% of patients vaccinated Covid patients, 750 Unvaccinated, 700 The scale of new infections and deaths has alarmed authorities so much that All workplaces, shut down for a week from the start of November Moscow, closing non-essential services for 11 days from next Thursday Very low vaccine uptake Years of scepticism of authorities Anti-vaxxers, social media

Learn more about your ad choices. Visit megaphone.fm/adchoices

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us